Management of DKA/HHS in Insulin Pump Patients
In a diabetic patient with an insulin pump who presents with DKA or HHS, immediately discontinue the insulin pump and initiate continuous intravenous insulin infusion as the standard of care for critically ill patients. 1, 2
Immediate Pump Discontinuation
The insulin pump must be stopped immediately upon recognition of DKA or HHS. This is critical because:
- Pump malfunction or catheter problems may have precipitated the crisis 3
- Subcutaneous insulin absorption is unreliable during severe metabolic decompensation
- The patient is likely mentally obtunded and cannot manage the device autonomously 4
Standard DKA/HHS Management Protocol
Initial Treatment Priorities
Fluid resuscitation is the first and most important intervention, followed by insulin therapy and electrolyte correction 5. The management approach is identical whether the patient normally uses a pump or not:
Aggressive IV fluid replacement - Several liters of physiological crystalloid solution to restore circulatory volume and tissue perfusion 1, 2, 5
Continuous IV insulin infusion - This is the standard of care for critically ill and mentally obtunded patients with DKA or HHS 1, 2. Use either regular insulin or rapid-acting analogs via continuous infusion 5
Electrolyte monitoring and replacement - Particularly potassium, which must be carefully monitored as both insulin and bicarbonate therapy lower serum potassium 6
Identify and treat precipitating causes - Sepsis, myocardial infarction, stroke, or in pump patients, equipment malfunction 1, 2
Monitoring Requirements
- Blood glucose, electrolytes, BUN, creatinine, osmolality, and venous pH every 2-4 hours 1, 6, 7
- Venous pH is adequate for monitoring; repeat arterial blood gases are generally unnecessary 6, 7
- Check for ketosis systematically when glucose >16.5 mmol/L (297 mg/dL) 4
Transition Back to Subcutaneous Insulin
Critical timing consideration: When transitioning from IV to subcutaneous insulin, you must administer basal insulin 2-4 hours BEFORE stopping the IV insulin infusion to prevent recurrence of ketoacidosis and rebound hyperglycemia 1, 2, 8. This is a common pitfall - premature termination of IV insulin or insufficient timing/dosing of subcutaneous insulin leads to treatment failure 8.
Criteria for Resolution Before Transition
DKA resolution requires ALL of the following 6, 7, 6:
- Glucose <200 mg/dL
- Serum bicarbonate ≥18 mEq/L
- Venous pH >7.3
For HHS: Confirm osmolality has decreased below 320 mOsm/L and mental status has improved 4
Pump Reconnection Decision
The personal insulin pump should only be reconnected when the patient can manage it autonomously 4. If the patient cannot manage the pump independently:
- Mandatory: Initiate a basal-bolus subcutaneous insulin regimen instead 4
- Use combination of long-acting (basal) insulin plus rapid-acting (bolus) insulin 4
- Do NOT simply restart the pump in a non-autonomous patient
Specific Pump Considerations
Before allowing pump reconnection, ensure:
- The patient is fully alert and oriented
- Pump malfunction has been ruled out as the precipitating cause 3
- The patient demonstrates competency in pump management
- Adequate diabetes education has been provided if pump misuse contributed to the crisis 3
Special Warnings
Gastrointestinal symptoms with mild hyperglycemia can be deceptive - Nausea, vomiting, and abdominal pain may indicate early ketoacidosis even when glucose elevation appears modest, particularly in pump patients where catheter leaks can cause rapid insulin deficiency 3.
For Type 2 diabetes patients, always consider hyperosmolar hyperglycemic state, which presents with variable and deceptive manifestations (fatigue, confusion, dehydration). Measure electrolytes urgently if suspected 4.
Bicarbonate therapy is generally not recommended - multiple studies show no benefit in resolution of acidosis or time to discharge, and it's only potentially beneficial if pH <6.9 1, 6, 7, 6.